Contraceptive Market Outlook for 2024 to 2034
Contraceptive Market Outlook for 2024 to 2034
Global Contraceptives Industry

Future Market Insights (FMI), a renowned leader in market research, has unveiled a comprehensive study projecting an impressive growth trajectory for the Global Contraceptives Industry. The market is expected to soar to a remarkable value of US$ 30.8 billion by the year 2032, fueled by a robust Compound Annual Growth Rate (CAGR) of 5.5%.

The groundwork for this anticipated surge was laid in 2022 when the Global Contraceptives Industry achieved a valuation of US$ 18 billion. FMI’s in-depth analysis underscores the pivotal role of both contraceptive drugs and devices in propelling this unprecedented growth.

In a significant revelation, FMI’s research highlights the dominance of contraceptive devices, projected to contribute approximately 58.3% to the market in 2021. This emphasizes the increasing global demand for innovative contraceptive solutions.

By the conclusion of 2029, the Global Contraceptives Industry size is anticipated to reach approximately US$ 33,529 million, marking a steady ascent at a CAGR of approximately 6.2% from 2019 to 2029. FMI attributes this sustained growth to various factors, including the escalating need for population control, a rise in unwanted pregnancies, and proactive government initiatives promoting contraceptive use.

FMI’s research methodology is recognized for its uniqueness, offering the most accurate and insightful analysis of the contraceptive market. As a result, industry stakeholders and decision-makers can rely on FMI’s findings to make informed choices in this dynamic market.

Request a Sample Copy of This Report Now.

It includes in-depth insights into the Global Contraceptives Industry. Some of these are:

  • The estimated value of the contraceptives market was at ~US$ 33,529 Mn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
  • Regionally, North America dominates the contraceptives market globally.
  • East Asia emerges as one of key markets owing to large population base, growing contraceptive awareness and initiatives taken by the respective country government.
  • Female segment holds the most of the contraceptive market as compared to men.
  • Key players are likely to focus on new product development in terms of drug & device, to stay relevant in developed markets.

Contraceptive Pills – the Most Lucrative Product Type

Contraceptive market contains drugs and devices. The devices market holds most the contraceptive market however drugs are anticipated to grow at highest CAGR owing to its beneficial property and easy consuming method. With the advancement of technology, the emergence of drugs have become popular as oral contraceptive pills which has the same purpose as other contraceptive drugs or devices. The simplicity and easy consumable method are expected to make it most popular contraceptive market. The other form of drugs such as topical and injectable contraceptives also witness strong market demand. Furthermore, these contraceptive pills are highly effective and does not interrupt in sex. Even in cases, it has been proved to reduce heavy and painful periods. All these factors and benefits are expected to fuel the sales of contraceptive drugs in the global market.

Ask the Market Research Expert

Some of the leading players operating in the Global Contraceptives Industry are Bayer AGPfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer, The Female Health Company and others. As a result of increasing competition, companies are focusing on expanding their product portfolio with new innovation. In addition to this, mergers and acquisition remains a popular strategy among market players. Companies intend to expand their regional footprint through strategic collaborations.

  • As a part of government’s initiative, the government of India had launched a new contraceptive pill named ‘Shukhi 3rd Generation’ in Nov 2019.
  • In Spet. 2019, Exeltis USA, Inc. had announced the Launch of Slynd(drospirenone) tablets, the First and only progestin-only pill providing pregnancy prevention with a 24-hour missed pill window

Get Valuable Insights into Global Contraceptives Industry

Future Market Insights, in its new report, presents an unbiased analysis of the Global Contraceptives Industry, covering historical demand data and forecast figures for the period between 2019 and 2029. The study divulges compelling insights on the contraceptives market based on product type (contraceptive drugs – oral contraceptive pills, injectable, topical), gender (male, female), by price range (high range, low /economy), sales channel (Wholesaler/ Distributor, Hypermarket/ Supermarket, Specialty Stores, Drug & Pharma Stores, Convenience Stores, online, and others -hospitals, clinics etc.), region (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa).

Access Exclusive Market Insights – Purchase Now!

Global Contraceptives Industry segmentation

Product Type

  • Contraceptive Drugs
    • Oral Contraceptive Pills
    • Injectables
    • Topical
  • Contraceptive Devices
    • Diaphgrams
    • Sponges
    • Vaginal Rings
    • Subdermal Implants
    • Intrauterine Device
    • Condom


  • Male
  • Female

Price Range

  • High Range
  • Low / Economy Range

Sales Channel

  • Wholesaler/ Distributor
  • Hypermarket/ Supermarket
  • Specialty Stores
  • Drug & Pharma Stores
  • Convenience Stores
  • Online
  • Others (hospitals, clinics etc.)

What's your reaction?


0 comment

Write the first comment for this!

Facebook Conversations